Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Hayriye Tatlı Doğan
Programmed Death Ligand 1 in Non-Clear Cell Renal Cell Carcinoma and Correlation With Tumor Microenvironment and Prognostic Factors
Medical Journal of Islamic World Academy of Sciences
Related publications
Catching Up With Solid Tumor Oncology: What Is the Evidence for a Prognostic Role of Programmed Cell Death-Ligand 1/Programmed Cell Death-1 Expression in B-Cell Lymphomas?
Haematologica
Hematology
Expression of Programmed Cell Death-Ligand 1 and Its Correlation With Clinical Outcomes in Gliomas
Oncotarget
Oncology
Prognostic Impact of CD8 and Programmed Death-Ligand 1 Expression in Patients With Resectable Non-Small Cell Lung Cancer
British Journal of Cancer
Cancer Research
Oncology
Higher Programmed Cell Death 1 Ligand 1 (PD-L1) mRNA Level in Clear Cell Renal Cell Carcinomas Is Associated With a Favorable Outcome Due to the Active Immune Responses in Tumor Tissues
Oncotarget
Oncology
Programmed Death-Ligand 1 Expression in Non-Small Cell Lung Carcinoma Biopsies and Its Association With Tumor Infiltrating Lymphocytes and the Degree of Desmoplasia
Klinicka Onkologie
Oncology
Expression and Prognostic Significance of MT1 Isoforms in Clear Cell Renal Cell Carcinoma
F1000Research
Genetics
Molecular Biology
Pharmacology
Biochemistry
Microbiology
Immunology
Medicine
Toxicology
Pharmaceutics
Prognostic Factors in Patients With Renal Cell Carcinoma
Japanese Journal of Urology
Urology
Prognostic Value of Granulocyte Colony-Stimulating Factor in Patients With Non-Metastatic Clear Cell Renal Cell Carcinoma
Oncotarget
Oncology
Potential Roles for PD‐1 and Cabozantinib in Patients With Metastatic Non‐Clear Cell Renal Cell Carcinoma
Oncologist
Cancer Research
Medicine
Oncology
